Trevena, Inc. (TRVN) To Host Conference Call On March 20th To Discuss Full Year 2013 Financial Results And Recent Highlights
3/14/2014 7:05:27 AM
Trevena, Inc. (NASDAQ: TRVN), a clinical stage pharmaceutical company focused on the discovery and development of G-protein coupled receptor (GPCR) biased ligands, today announced that it will host a conference call on Thursday, March 20, 2014 at 11:00 a.m. Eastern Time to discuss corporate updates and financial results for the year ended December 31, 2013.
Help employers find you! Check out all the jobs and post your resume.
comments powered by